Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Monsanto Co. -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (492)	11/10/1998 6:34:00 PM
From: twt	Read Replies (1) \| Respond to of 2539

I guess Merck is not that far behind. Even if MRK were to submit tomorrow, it won't be approved til next May/June 99? MTC hopefully will have close to 6 mos head start. Since MRK's better (MRK needs one pill per day but MTC requires two per day) I would think the FDA may approve MRK's faster than I would think (6 mos for fast track review). Anyway, are these two drugs identical in terms of 'ingredients' for lack of better terms and are they treating the same kinda symptons? Thanks.